NDC 0168-0041

Betamethasone Valerate

Betamethasone Valerate

Betamethasone Valerate is a Topical Lotion in the Human Prescription Drug category. It is labeled and distributed by E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc.. The primary component is Betamethasone Valerate.

Product ID0168-0041_2083265f-3850-458f-8744-b96d68f2a062
NDC0168-0041
Product TypeHuman Prescription Drug
Proprietary NameBetamethasone Valerate
Generic NameBetamethasone Valerate
Dosage FormLotion
Route of AdministrationTOPICAL
Marketing Start Date1983-08-31
Marketing CategoryNDA / NDA
Application NumberNDA018866
Labeler NameE. Fougera & Co. a division of Fougera Pharmaceuticals Inc.
Substance NameBETAMETHASONE VALERATE
Active Ingredient Strength1 mg/mL
Pharm ClassesCorticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0168-0041-60

60 mL in 1 BOTTLE (0168-0041-60)
Marketing Start Date1983-08-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0168-0041-60 [00168004160]

Betamethasone Valerate LOTION
Marketing CategoryNDA
Application NumberNDA018866
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1983-08-31

Drug Details

Active Ingredients

IngredientStrength
BETAMETHASONE VALERATE1 mg/mL

OpenFDA Data

SPL SET ID:0b386ccc-a2d4-4d18-a2d7-e46ff894c674
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197409
  • 197408
  • 197407
    • UPC Code
  • 0301680040158

    • Pharmacological Class

    • Corticosteroid [EPC]
    • Corticosteroid Hormone Receptor Agonists [MoA]
    • Corticosteroid [EPC]
    • Corticosteroid Hormone Receptor Agonists [MoA]

    NDC Crossover Matching brand name "Betamethasone Valerate" or generic name "Betamethasone Valerate"

    NDCBrand NameGeneric Name
    0168-0033Betamethasone Valeratebetamethasone valerate
    0168-0040Betamethasone Valeratebetamethasone valerate
    0168-0041Betamethasone Valeratebetamethasone valerate
    0378-8180Betamethasone ValerateBetamethasone Valerate
    0472-0370Betamethasone ValerateBetamethasone Valerate
    0472-0371Betamethasone ValerateBetamethasone Valerate
    0713-0326Betamethasone ValerateBetamethasone Valerate
    0713-0327Betamethasone ValerateBetamethasone Valerate
    21695-584Betamethasone ValerateBetamethasone Valerate
    21695-586Betamethasone Valeratebetamethasone valerate
    45802-053Betamethasone ValerateBetamethasone Valerate
    50090-0165Betamethasone Valeratebetamethasone valerate
    50090-0237Betamethasone ValerateBetamethasone Valerate
    50090-0309Betamethasone ValerateBetamethasone Valerate
    50090-1647BETAMETHASONE VALERATEBetamethasone Valerate
    50090-3134BETAMETHASONE VALERATEBetamethasone Valerate
    50090-3794Betamethasone ValerateBetamethasone Valerate
    50090-4696Betamethasone ValerateBetamethasone Valerate
    50742-315Betamethasone ValerateBetamethasone Valerate
    68071-4441Betamethasone ValerateBetamethasone Valerate
    68071-4278BETAMETHASONE VALERATEBETAMETHASONE VALERATE
    68788-7397Betamethasone ValerateBetamethasone Valerate
    68788-0597Betamethasone ValerateBetamethasone Valerate
    68788-7312Betamethasone ValerateBetamethasone Valerate
    68788-7095Betamethasone ValerateBetamethasone Valerate
    70518-0721Betamethasone ValerateBetamethasone Valerate
    70518-1177BETAMETHASONE VALERATEBETAMETHASONE VALERATE
    71205-040Betamethasone ValerateBetamethasone Valerate
    51672-4188Betamethasone ValerateBetamethasone Valerate
    51672-1269BETAMETHASONE VALERATEBETAMETHASONE VALERATE
    53002-9210Betamethasone ValerateBetamethasone Valerate
    54879-004Betamethasone ValerateBetamethasone Valerate
    63187-687Betamethasone ValerateBetamethasone Valerate
    63187-276Betamethasone ValerateBetamethasone Valerate
    66267-984Betamethasone ValerateBetamethasone Valerate
    71205-364Betamethasone ValerateBetamethasone Valerate
    0378-8187LuxiqBetamethasone Valerate
    40076-021LuxiqBetamethasone Valerate
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.